3Brain aims to establish partnerships with pharmaceutical companies and CROs for projects featuring its multi-well high-density MEA technology in experimental contexts. In addition to the opportunity to refine 3Brain’s systems for high-throughput in vitro screening, partners will have access to: electrophysiological imaging for advanced preclinical drug screening, cutting edge technology, custom-made solutions and a free evaluation period.
|